Results 131 to 140 of about 62,039 (256)

Proton Pump Inhibitors Prescribing Behaviors and Rationalization Strategies Among Healthcare Providers in Southeast Asia. [PDF]

Pharmacol Res Perspect
Quach DT, Huynh TM, Galang AJG, Dao HV, Chirapongsathorn S, Kijdamrongthum P, Khan RA, Ong AM, Cheah WK, Khaira KS, Tan SF, Sollano J, Syam AF, Chua TS, Leelakusolvong S, Lee YY.   +15 more
europepmc   +1 more source

The safety of proton pump inhibitors [PDF]

Alimentary Pharmacology & Therapeutics, 2001
openaire   +2 more sources

Vonoprazan vs Proton Pump Inhibitors for Gastroprotection in Anticoagulated Patients: A Real-World Cohort Study. [PDF]

Cureus
Ahmed H, Alabdul Razzak I, Abdulrazzak E, Gomaa S, Abdelrazeq K, Korimilli A, Khetarpal R, Almahmood M, Shahzad A, Elsokary K.   +9 more
europepmc   +1 more source

Impact of Perioperative Proton Pump Inhibitors on Renal Cancer Progression. A Retrospective Study. [PDF]

Cancer Med
Cortes-Mejia N, Wong R, Eltzschig HK, Moreno-Lopez SM, Bejarano-Ramirez D, Huang H, Cata JP.   +6 more
europepmc   +1 more source

Nonvariceal Upper GI Bleeding in Established Users of Proton-Pump Inhibitors: Higher Incidence But Better Outcomes. [PDF]

Clin Transl Gastroenterol
Taha AS, McCloskey C, Craigen T, Angerson WJ.   +3 more
europepmc   +1 more source

The Choice of a Proton Pump Inhibitor [PDF]

Basic & Clinical Pharmacology & Toxicology, 2004
openaire   +2 more sources

Renal Outcomes With Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors in CKD. [PDF]

Kidney Int Rep
Kim SY, Lee H, Kim JS, Kim JH, Jeon HL.
europepmc   +1 more source

Integrating One Health to Mitigate the Emergence and Spread of Antimicrobial Resistance in Livestock and Aquaculture

Animal Research and One Health, EarlyView.
Antimicrobial resistance (AMR) is an escalating global threat driven by antimicrobial use in aquaculture and livestock. Resistant pathogens and genes can spread across humans, animals, and the environment through interconnected ecosystems. Using a One Health approach, this review emphasizes antimicrobial stewardship, regulatory strengthening, enhanced ...
Mir Mohammad Ali, Delower Hossain, Ridwan Olamilekan Adesola, Anum Hanif, Shamsaldeen Ibrahim Saeed, Muhammad Abdul Mannan, Anoar Jamai Masroure, Kazi Estieque Alam, Md Kamal Hossain, Sabiha Zarin Tasnim Bristi, Md Jisan Ahmed   +10 more
wiley   +1 more source

Proton pump inhibitors modulate esophageal epithelial barrier function and crosstalk with eosinophils. [PDF]

Pediatr Allergy Immunol
Gautam R, Lal M, Carroll MC, Mrozek Z, Trachsel T, Beers J, Ruffner MA.   +6 more
europepmc   +1 more source

Prescribing of Medication to Prevent Glucocorticoid Harms in Patients With Polymyalgia Rheumatica: A Cross‐Sectional Study and Two Emulated Target Trials in the Clinical Practice Research Datalink Aurum

Arthritis &Rheumatology, EarlyView.
Objective Polymyalgia rheumatica (PMR) is a common indication for long‐term glucocorticoid (GC) treatment. Bone‐protective and gastroprotective medications are recommended for those at high risk of adverse events from GCs, but no trials have evaluated their effectiveness in PMR.
Helen Twohig, David Jenkinson, James Bailey, Samantha Hider, Ian C. Scott, Sara Muller   +5 more
wiley   +1 more source